Construction and analysis of a lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy

Chen,Kai; Ma,Yunci; Wu,Shaoyu; Zhuang,Yuxin; Liu,Xin; Lv,Lin; Zhang,Guohua

doi:10.3892/mmr.2019.10361

Construction and analysis of a lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy

Authors:
- Kai Chen
- Yunci Ma
- Shaoyu Wu
- Yuxin Zhuang
- Xin Liu
- Lin Lv
- Guohua Zhang
View Affiliations

Affiliations: School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510000, P.R. China, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: June 6, 2019 https://doi.org/10.3892/mmr.2019.10361
Pages: 1393-1403

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic cardiomyopathy (DCM) is a major cause of mortality in patients with diabetes, particularly those with type 2 diabetes. Long non‑coding RNAs (lncRNAs), including terminal differentiation‑induced lncRNA (TINCR), myocardial infarction‑associated transcript (MIAT) and H19, serve a key role in the regulation of DCM. MicroRNAs (miRNAs/miRs) can inhibit the expression of mRNA at the post‑transcriptional level, whereas lncRNAs can mask the inhibitory effects of miRNAs on mRNA. Together, miRNAs and lncRNAs form a competitive endogenous non‑coding RNA (ceRNA) network that regulates the occurrence and development of various diseases. However, the regulatory role of lncRNAs in DCM is unclear. In this study, a background network containing mRNAs, miRNAs and lncRNAs was constructed using starBase and a regulatory network of DCM was screened using Cytoscape. A functional lncRNA, X‑inactive specific transcript (XIST), was identified in the disease network and the main miRNAs (miR‑424‑5p and miR‑497‑5p) that are regulated by XIST were further screened to obtain the ceRNA regulatory network of DCM. In conclusion, the results of this study revealed that lncRNAs may serve an important role in DCM and provided novel insights into the pathogenesis of DCM.

View Figures

View References

1	Jia G, Whaley-Connell A and Sowers JR: Diabetic cardiomyopathy: A hyperglycaemia-and insulin-resistance-induced heart disease. Diabetologia. 61:21–28. 2018. View Article : Google Scholar : PubMed/NCBI
2	Seferović PM and Paulus WJ: Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 36:1718–1727. 2015. View Article : Google Scholar : PubMed/NCBI
3	Lam CS: Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Diab Vasc Dis Res. 12:234–238. 2015. View Article : Google Scholar : PubMed/NCBI
4	Aneja A, Tang WH, Bansilal S, Garcia MJ and Farkouh ME: Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 121:748–757. 2008. View Article : Google Scholar : PubMed/NCBI
5	Taft RJ, Pang KC, Mercer TR, Dinger M and Mattick JS: Non-coding RNAs: Regulators of disease. J Pathol. 220:126–139. 2010. View Article : Google Scholar : PubMed/NCBI
6	Iwakawa H and Tomari Y: The functions of MicroRNAs: MRNA decay and translational repression. Trends Cell Biol. 25:651–665. 2015. View Article : Google Scholar : PubMed/NCBI
7	Jandura A and Krause HM: The New RNA World: Growing Evidence for long noncoding RNA functionality. Trends Genet. 33:665–676. 2017. View Article : Google Scholar : PubMed/NCBI
8	Li W, Notani D and Rosenfeld MG: Enhancers as non-coding RNA transcription units: Recent insights and future perspectives. Nat Rev Genet. 17:207–223. 2016. View Article : Google Scholar : PubMed/NCBI
9	Thum T and Condorelli G: Long Noncoding RNAs and MicroRNAs in cardiovascular pathophysiology. Circ Res. 116:751–762. 2015. View Article : Google Scholar : PubMed/NCBI
10	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA Hypothesis: The rosetta stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
11	Smillie CL, Sirey T and Ponting CP: Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk. Crit Rev Biochem Mol Biol. 53:231–245. 2018. View Article : Google Scholar : PubMed/NCBI
12	Shi X, Sun M, Liu H, Yao Y and Song Y: Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
13	Dong Y, Liu C, Zhao Y, Ponnusamy M, Li P and Wang K: Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases. Cell Mol Life Sci. 75:291–300. 2018. View Article : Google Scholar : PubMed/NCBI
14	Zhang M, Gu H, Chen J and Zhou X: Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy. Int J Cardiol. 202:753–755. 2016. View Article : Google Scholar : PubMed/NCBI
15	Zhou X, Zhang W, Jin M, Chen J, Xu W and Kong X: lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis. 8:e29292017. View Article : Google Scholar : PubMed/NCBI
16	Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L and Martelli F: MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes. 61:1633–1641. 2012. View Article : Google Scholar : PubMed/NCBI
17	Ismail M, Suresh H, Nazrath N, Anisatu R, Marian P, Bruno V, Fabrizio S and Conrad B: GeoDiver: Differential gene expression analysis & gene-set analysis for GEO Datasets. Queen Mary J Intellectual Property. Apr 15–2017.doi: https://doi.org/10.1101/127753.
18	Harel A, Inger A, Stelzer G, Strichman-Almashanu L, Dalah I, Safran M and Lancet D: GIFtS: Annotation landscape analysis with GeneCards. BMC Bioinformatics. 10:3482009. View Article : Google Scholar : PubMed/NCBI
19	Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and Galon J: ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
20	Kanehisa M, Furumichi M, Tanabe M, Sato Y and Morishima K: KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017. View Article : Google Scholar : PubMed/NCBI
21	Su G, Morris JH, Demchak B and Bader GD: Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 47:1–24. 2014. View Article : Google Scholar : PubMed/NCBI
22	Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP and Vidal M: Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature. 430:88–93. 2004. View Article : Google Scholar : PubMed/NCBI
23	Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, et al: Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2:2366–2382. 2007. View Article : Google Scholar : PubMed/NCBI
24	Zhou B, Wang B and Zhe H: Degree-layer theory of network topology. Phys Soc. 18–Sep;2014.
25	Fromm B, Billipp T, Peck LE, Johansen M, Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E and Peterson KJ: A Uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome. Annu Rev Genet. 49:213–242. 2015. View Article : Google Scholar : PubMed/NCBI
26	Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B and Rigoutsos I: A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 126:1203–1217. 2006. View Article : Google Scholar : PubMed/NCBI
27	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nature Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
28	Betel D, Koppal A, Agius P, Sander C and Leslie C: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11:R902010. View Article : Google Scholar : PubMed/NCBI
29	Carrel L and Willard HF: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 434:400–404. 2005. View Article : Google Scholar : PubMed/NCBI
30	Marques FZ, Vizi D, Khammy O, Mariani JA and Kaye DM: The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail. 18:1000–1008. 2016. View Article : Google Scholar : PubMed/NCBI
31	Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y and Ramakrishnan S: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest. 120:4141–4154. 2010. View Article : Google Scholar : PubMed/NCBI
32	Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, Finn SP, Russell S, Ring M, Denning KM, Li J, et al: Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol. 22:197–205. 2009. View Article : Google Scholar : PubMed/NCBI
33	Finnerty JR, Wang WX, Hébert SS, Wilfred BR, Mao G and Nelson PT: The miR-15/107 group of microRNA genes: Evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol. 402:491–509. 2010. View Article : Google Scholar : PubMed/NCBI
34	Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang Z, Hu K, Dong P and Han X: The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep. 7:409582017. View Article : Google Scholar : PubMed/NCBI
35	Jafarzadeh M, Soltani BM, Dokanehiifard S, Kay M, Aghdami N and Hosseinkhani S: Experimental evidences for hsa-miR-497-5p as a negative regulator of SMAD3 gene expression. Gene. 586:216–221. 2016. View Article : Google Scholar : PubMed/NCBI
36	Gendrel AV and Heard E: Fifty years of X-inactivation research. Development. 138:5049–5055. 2011. View Article : Google Scholar : PubMed/NCBI
37	Payer B and Lee JT: X chromosome dosage compensation: How mammals keep the balance. Annu Rev Genet. 42:733–772. 2008. View Article : Google Scholar : PubMed/NCBI
38	Wei W, Liu Y, Lu Y, Yang B and Tang L: LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
39	Song H, He P, Shao T, Li Y, Li J and Zhang Y: Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. J BUON. 22:696–703. 2017.PubMed/NCBI
40	Zhou T, Qin G, Yang L, Xiang D and Li S: LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p. J Cell Physiol. 234:8659–8667. 2019. View Article : Google Scholar : PubMed/NCBI
41	Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE and Vlassara H: Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: Potential role of AGER1 and SIRT1. Diabetes Care. 34:1610–1616. 2011. View Article : Google Scholar : PubMed/NCBI
42	Prasad K: Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: Myth or Reality. Int J Angiol. 23:11–16. 2014. View Article : Google Scholar : PubMed/NCBI
43	Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ and Tan KC: Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes. Clin Sci (Lond). 120:81–89. 2011. View Article : Google Scholar : PubMed/NCBI
44	Gao X, Zhang H, Schmidt AM and Zhang C: AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 295:H491–H498. 2008. View Article : Google Scholar : PubMed/NCBI
45	Villegas-Rodríguez ME, Uribarri J, Solorio-Meza SE, Fajardo-Araujo ME, Cai W, Torres-Graciano S, Rangel-Salazar R, Wrobel K and Garay-Sevilla ME: The AGE-RAGE axis and its relationship to markers of cardiovascular disease in newly diagnosed diabetic patients. PLoS One. 11:e01591752016. View Article : Google Scholar : PubMed/NCBI
46	Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, et al: Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 57:2461–2469. 2008. View Article : Google Scholar : PubMed/NCBI